Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 4, 1997, Pages 702-715

  Den Boer, Jacques A ^a,d   Hoenderop, Ruud K K M ^a   Smink, Jouke ^b   Dornseiffen, Gerard ^a   Koch, Paul W A A ^a   Mulder, Jan H ^a   Slump, Cornelis H ^b   Volker, Edo D P ^a   De Vos, Rob A I ^c  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Department of Cytogenetics   (Netherlands)

^d NONE   (Netherlands)

Author keywords

Gd DTPA; Magnetic resonance Imaging; Pharmacokinetics Breast lesions

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST LESION; BREAST TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; OCCULT CANCER; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUMOR DIAGNOSIS;

BREAST; BREAST DISEASES; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; SENSITIVITY AND SPECIFICITY;

EID: 0031404177     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070416     Document Type: Article

References (44)

1. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
2. Stack JP, Redmond OM, Codd M, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494.
3. Lewis Jones HG, Whitehouse GH, Leinster SJ. The role of MR imaging in the assessment of local recurrent breast carcinoma. Clin Radiol 1993; 43:117-204.
4. Klengel S, Hietschold V, Schreiber M, Kohler K. Quantitative kontrastmitteldynamische mamma-MRT am 0.5 Tesla gerät. Rontgenpraxis 1994; 47:223-228.
5. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time intensity. Magn Reson Imaging 1993; 11:617-620.
6. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography. A technique for potentially reducing the biopsy rate for benign breast disease. J Magn Reson Imaging 1994; 4:563-568.
7. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197:387-395.
8. Hickman PF, Moore NR, Shepstone BJ. The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging. Br J Radiol 1994; 67(793):14-20.
9. Gilles R, Zafrani B, Guinebretiere JM, et al. Ductal carcinoma in situ: MR imaging - histopathologic correlation. Radiology 1995; 196:415-419.
10. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in dynamic MRI of the breast and tumour angiogenesis. Invest Radiol 1994, 29:1043-1049.
11. Heywang SH, Wolf A, Pruss E, Hilbertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103.
12. Harms SE, Flamig DP. MR imaging of the breast. J Magn Reson Imaging 1993; 3:277-283.
13. Rigauts H, Casselman J, Steyart L, Devlies F, Pattijn G. Contribution of MRI and colour doppler Sonography in breast cancer. J Belge Radiol 1993; 76:226-231.
14. Greenstein Orel S, Schnall MD, Levels V, Trepan RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
15. Perman WH, Heiberg EM, Grunz J, Herrmann VM, Janney CG. A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions. Magn Reson Imaging 1994; 12:545-551.
16. Den Boer JA, Dornseiffen G, Elevelt A, et al. Quantitative 3D temporal tracking of redistribution of Gd-DTPA in the mamma (abstract). J Magn Reson Imaging 1993; 4:90.
17. Smink J, den Boer JA, Dornseiffen G, et al. Breast lesion differentiation based on the pharmacokinetic behavior of Gd-DTPA. J Magn Reson Imaging 1994; 4:90.
18. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994; 193: 777-781.
19. Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. J Magn Reson Imaging 1994; 4:477-480.
20. Tofts P, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
21. Hulka PS, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995; 197:33-38.
22. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17: 357-367.
23. Hess T, Knopp MV, Hoffmann U, et al. A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1994; 160:518-523.
24. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33:506-514.
25. Kruger RA, Riederer S, eds. Basic concepts of digital subtraction angiography. Boston: G.K. Hall, 1984;210-217.
26. Windham JP, Abd-Allah MA, Reimann DA, Froelich JW, Haggar AM. Eigenimage filtering in MR imaging. J Comput Assist Tomogr 1988; 12:1-9.
27. Press WH, Flannery BP, Teukolski SA, Vetterling WT, eds. Modelling of data. In: Numerical recipes in C, the art of scientific computing. Cambridge University Press, Cambridge, UK, 1988; 517-565.
28. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
29. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
30. Ganong WF. The general and cellular basis of medical physiology. In: Ganong WF, ed. Review of medical physiology. Norwalk, CT: Appleton & Lange, 1989; 1-2.
31. Schmidt RF, Thews G. Human physiology. New York: Springer Verlag, 1983.
32. International Commission on Radiation Protection. Report of the task group on reference man. ICRP publication 23. Oxford: Pergamon Press, 1975; 32.
33. Furman-Haran E, Margalit R, Grobgeld D, Degani H. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc Natl Acad Sci USA 1996; 93:6247-6251.
34. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845.
35. Van der Meulen P, Groen JP, Tinus AMC, Bruntink G. Fast field echo imaging: an overview and contrast calculations. Magn Reson Imaging 1988; 6:355-368.
36. Wang HZ, Riederer SJ, Lee JN. Optimizing the precision in Tl relaxation estimation using limited flip angles. Magn Reson Med 1987; 5:399-416.
37. Weinmann HJ, Brasch RC, Pres WR, Wesby GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984; 42:619-624.
38. Weinmann HJ, Laniado M, Mützel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984; 16: 167-172.
39. Roland M, Thosar TN. Clinical pharmacokinetics, concepts and applications. Philadelphia: Lea & Febiger, 1980.
40. Koenig SH, Spiller M, Brown RD, et al. Relaxation of water protons in the intra and extra cellular regions of blood containing Gd(DTPA). Magn Reson Med 1986; 3:791-795.
41. Bassingthwaighte JB. Microcirculatory considerations in NMR flow imaging. Magn Reson Med 1990; 14:172-178.
42. Tofts PS, Shuter B, Pope JM. Ni-DTPA doped agarose gel - a phantom material for Gd-DTPA enhancement. Magn Reson Imaging 1993; 11:125-133.
43. Lerski RA, McRobbie DW, de Certaines JD. Protocols and test objects for the assessment of MRI equipment. Magn Reson Imaging 1988; 6:195-199.
44. Gore JC, Majumdar S. Measurement of tissue blood flow using intravascular relaxation agents and magnetic resonance imaging. J Magn Reson 1988; 78:41-55.